Inventor

CALDWELL CHARLES G

US23 patents

⚠️ This page may combine multiple inventors who share the name “CALDWELL CHARLES G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CALDWELL CHARLES G

MERCK & CO INC

Hexahydro-5-imino-1,4-1,4-thiazepine derivatives as inhibitors of nitric oxide synthases

Cycloalkyl tachykinin receptor antagonists

Phenyl spiroethercycloalkyl tachykinin receptor antagonists

Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Pyrrolidine modulators of chemokine receptor activity

Cyclic amine modulators of chemokine receptor activity

Cyclic amine modulations of chemokine receptor activity

Substituted thiazoles as immunoregulants

Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases

Cyclic amidine analogs as inhibitors of nitric oxide synthase

3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Pyrrolidine modulators of chemokine receptor activity

Cyclic amine modulators of chemokine receptor activity

6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis

Substituted cyclic derivatives as novel antidegenerative agents

Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents

Aryl-substituted thiophene 3-ols, derivatives and analogs useful as lipoxgenase inhibitors

Substituted N-carboxyalkylpeptidyl derivatives as antidegenerative active agents

3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Pyrrolidine modulators of CCR5 chemokine receptor activity

MERCK SHARP & DOHME

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

UNIV TEXAS

Inhibition of HIF-2α heterodimerization with HIF1β (ARNT)